In the early stage of acute myocardial infarction, the release of cTnI is increased with high specificity and sensitivity. It is considered as a preferred cardiac marker in diagnosis of myocardial infarction. cTnI can be used for diagnosis, risk classification and prognosis assessment of myocardial infarction to help Clinical determination and adjustment.